Automated Sample Multiplexing by using Combined Precursor Isotopic Labeling and Isobaric Tagging (cPILOT)
December 18th, 2020
5.4K views
Combined precursor isotopic labeling and isobaric tagging (cPILOT) is an enhanced sample multiplexing strategy that is capable of increasing the number of samples that can be analyzed simultaneously with available isobaric tags. Incorporation of a robotic platform has greatly increased experimental throughput, reproducibility, and quantitative accuracy.
Overview
The combined precursor isotopic labeling and isobaric tagging (cPILOT) protocol enhances sample multiplexing, allowing for simultaneous analysis of multiple samples. This method improves throughput, reproducibility, and quantitative accuracy in biological research.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Proteomics
Background
- cPILOT integrates isotopic labeling with isobaric tagging.
- It is particularly useful for studying diseases like Alzheimer's.
- The technique allows for high-throughput analysis of biological samples.
- Robotic platforms enhance the efficiency of the protocol.
Purpose of Study
- To streamline the analysis of biological samples.
- To reduce errors in high-throughput sample processing.
- To facilitate quicker access to biological information related to diseases.
Methods Used
- Automated sample preparation using a robotic platform.
- Sequential addition of reagents for sample processing.
- Dimethylation labeling followed by isobaric tagging.
- Desalting and purification of peptides for analysis.
Main Results
- Increased throughput and accuracy in sample analysis.
- Successful application of cPILOT in studying aging and Alzheimer's.
- Demonstrated reduction in actionable errors during sample processing.
- Protocol allows for parallel processing of multiple samples.
Conclusions
- cPILOT is a valuable tool for high-throughput biological research.
- The method enhances the efficiency of proteomic studies.
- It has broad applications in various disease research contexts.
Frequently Asked Questions
What is cPILOT?
cPILOT stands for combined precursor isotopic labeling and isobaric tagging, a method for analyzing multiple samples simultaneously.
How does cPILOT improve sample analysis?
It enhances throughput, reproducibility, and quantitative accuracy by allowing parallel processing of samples.
What diseases can be studied using cPILOT?
cPILOT can be applied to various diseases, including Alzheimer's and other conditions involving biological tissues.
What role does automation play in cPILOT?
Automation increases the efficiency and accuracy of the sample preparation process.
Can cPILOT be used for other types of biological research?
Yes, it is versatile and can be adapted for various biological studies beyond aging and Alzheimer's.
Executive Industry Relevance
Automated cPILOT enables high-throughput, quantitative proteomics by multiplexing up to 24 samples in a single mass spectrometry experiment, directly addressing bottlenecks in sample processing and data acquisition. This workflow reduces manual error, increases reproducibility, and accelerates actionable biological insights for disease-relevant research. Its integration into automated platforms positions it as a scalable solution for enterprise-level discovery and translational pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables robust quantitative comparison of protein expression across multiple biological conditions or disease models.
- Supports functional target validation by minimizing sample variability and maximizing data consistency.
- Facilitates rapid hypothesis testing through parallelized sample processing and analysis.
Screening & Assay Development
- Prepares standardized, multiplexed samples for downstream mass spectrometry-based screening workflows.
- Delivers reproducible, quantitative outputs suitable for high-throughput assay development.
- Reduces inter-sample variability, supporting reliable compound or biomarker evaluation.
Translational & Preclinical Research
- Aligns proteomic data generation with disease-relevant tissue and biofluid analysis.
- Enables continuity from discovery through preclinical validation by supporting large-scale, comparative studies.
- Provides quantitative metrics that inform risk-adjusted advancement decisions in translational research.
Pipeline & Workflow Integration
Automated cPILOT fits within the discovery-to-preclinical continuum, enabling multiplexed quantitative proteomics from early target validation through translational research.
- Discovery Biology: Supports hypothesis-driven interrogation of protein expression changes across experimental conditions.
- Screening: Provides assay-ready, multiplexed samples with minimized technical variability.
- Analytics: Generates quantitative reporter ion data for robust statistical comparison of sample groups.
- Translational Research: Facilitates large-scale, disease-relevant proteomic profiling for biomarker discovery.
- Enterprise Reuse: Adaptable to various tissues, cell lysates, and biofluids, supporting broad R&D portfolio needs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in protein quantitation.
- Operational Value: Standardizes and automates complex sample preparation, improving reproducibility and throughput.
- Strategic Value: Enables faster, data-driven go/no-go decisions and enhances capital efficiency in discovery programs.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of multiple candidates or conditions in parallel.
Implementation Considerations
- Requires expertise in quantitative proteomics and automated liquid handling systems.
- Needs access to compatible robotic platforms and mass spectrometry infrastructure.
- Demands rigorous cross-team standardization of sample labeling and tag assignment.
- Adaptable across diverse biological matrices, but careful planning of tag/sample mapping is essential.
- Potential limitations include the need for precise reagent handling and validation of automation protocols.
Biopharma FAQs
Why does null hypothesis testing matter for cPILOT target validation?
Null hypothesis testing in cPILOT experiments enables objective assessment of protein abundance differences across multiplexed samples, supporting confident target validation decisions. Quantitative outputs from reporter ions allow statistical comparison between experimental groups. This reduces the risk of false positives in early discovery pipelines.
How does independent variable isolation fit in automated cPILOT workflows?
Automated cPILOT workflows allow precise assignment of isotopic and isobaric tags to specific samples, ensuring that only the intended experimental variable differs between groups. This isolation supports accurate attribution of observed proteomic changes to the variable of interest. It strengthens mechanistic de-risking and data interpretability.
What do quantitative dependent variable measurements enable in cPILOT?
Quantitative measurement of reporter ion intensities enables direct comparison of protein abundance across all multiplexed samples. This supports robust statistical analysis and identification of biologically meaningful changes. It also facilitates prioritization of targets or conditions for further study.
Why are replication requirements critical for cross-functional cPILOT studies?
Replication in automated cPILOT ensures low inter-sample and inter-well variability, as demonstrated by low coefficients of variation in reporter ion abundance. This reproducibility is essential for cross-functional teams to trust and act on proteomic data. It underpins collaborative decision-making in multi-site or multi-project environments.
What statistical analysis capabilities are needed before cPILOT implementation?
Effective cPILOT deployment requires statistical tools for analyzing reporter ion intensities, calculating coefficients of variation, and comparing abundance across channels. These capabilities ensure data quality and support rigorous interpretation of multiplexed proteomic results. They are foundational for integrating cPILOT outputs into enterprise R&D workflows.
